BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 2007
View Archived Issues
Preclinical and clinical data on novel inhibitors of HCV NS5B polymerase and NS3 proteases
Read More
Clinical studies of bifeprunox presented
Read More
Snapshots of drugs being evaluated for schizophrenia
Read More
Recent patents impart new treatments for cardiovascular disorders
Read More
New treatment options for inflammatory disorders reported in recent patents
Read More
In vitro and in vivo characterization of an orally active VEGF/PDGF inhibitor
Read More
New therapeutic agents for cancer covered in recent patent literature
Read More
AZD-7762, a potent and selective Chk kinase inhibitor, potentiates activity of DNA-damaging agents
Read More
Novel Met inhibitor from Pfizer with potential in osteosarcoma
Read More
First-in-class non-ATP-selective Src inhibitor designed by Kinex
Read More
Phase I results in cancer patients reported for CDK inhibitor P-276-00
Read More
FDA grants orphan drug status to ganciclovir for acute herpetic keratitis
Read More
Clearance for phase I Japanese study of nimotuzumab for solid tumors
Read More
Inecalcitol shows high level of tolerance in phase I trial
Read More
SPRC-AB01 granted fast track status for chronic sinusitis
Read More
KD-7040 begins second phase I study for neuropathic pain
Read More
Phase III confirmatory study of DX-88 for HAE begins treatment
Read More
New Zealand regulator approves phase I/IIa study of DiabeCell
Read More
Indevus and Valera complete merger
Read More
Alnylam to advance ALN-VSP01 for liver cancer
Read More
FDA licenses first U.S. avian influenza vaccine for humans
Read More
Polyphenon E Ointment accepted for review in Germany, Austria, and Spain
Read More
Neupro studied for sleep problems, early morning motor symptoms in Parkinson's
Read More
Prevascar improves scar appearance following incisional wounds
Read More
Biliary fibrosis aggravated by the antiangiogenic alpha(v)beta(3) antagonist cilengitide in rats
Read More
Arixtra approved in Japan
Read More
Japanese approval for Alvesco
Read More
Uritos approved for overactive bladder in Japan
Read More
Valtrex approved in Japan for pediatric varicella
Read More
Zetia approved in Japan
Read More